These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 7053268)
41. Schedule- and dose-intensified paclitaxel as weekly 1-hour infusion in pretreated solid tumors: results of a phase I/II trial. Löffler TM; Freund W; Lipke J; Hausamen TU Semin Oncol; 1996 Dec; 23(6 Suppl 16):32-4. PubMed ID: 9007118 [TBL] [Abstract][Full Text] [Related]
42. A phase I and pharmacokinetic study of Col-3 (Metastat), an oral tetracycline derivative with potent matrix metalloproteinase and antitumor properties. Syed S; Takimoto C; Hidalgo M; Rizzo J; Kuhn JG; Hammond LA; Schwartz G; Tolcher A; Patnaik A; Eckhardt SG; Rowinsky EK Clin Cancer Res; 2004 Oct; 10(19):6512-21. PubMed ID: 15475438 [TBL] [Abstract][Full Text] [Related]
43. Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer. Raymond E; Alexandre J; Faivre S; Vera K; Materman E; Boni J; Leister C; Korth-Bradley J; Hanauske A; Armand JP J Clin Oncol; 2004 Jun; 22(12):2336-47. PubMed ID: 15136596 [TBL] [Abstract][Full Text] [Related]
44. Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology Group. Knight WA; Fabian C; Costanzi JJ; Jones SE; Coltman CA Invest New Drugs; 1983; 1(3):235-7. PubMed ID: 6678871 [TBL] [Abstract][Full Text] [Related]
45. Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group. Knight WA; Drelichman A; Fabian C; Bukowski RM Cancer Treat Rep; 1983 Dec; 67(12):1139-40. PubMed ID: 6652631 [No Abstract] [Full Text] [Related]
46. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung. Scher H; Chapman R; Kelsen D; Gralla R; Wittes R Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989 [No Abstract] [Full Text] [Related]
47. Phase II trial of mitoguazone in patients with advanced head and neck cancer. Thongprasert S; Bosl GJ; Geller NL; Wittes RE Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604 [No Abstract] [Full Text] [Related]
49. Effectiveness of methyl-GAG (methylglyoxal-bis[guanylhydrazone]) in patients with advanced malignant lymphoma. Warrell RP; Lee BJ; Kempin SJ; Lacher MJ; Straus DJ; Young CW Blood; 1981 Jun; 57(6):1011-4. PubMed ID: 7013854 [TBL] [Abstract][Full Text] [Related]
50. Phase I evaluation of a weekly schedule of anguidine. Southeastern Cancer Study Group Committee on Gastrointestinal Malignancies. DeSimone PA; Greco FA; Lessner HF Cancer Treat Rep; 1979; 63(11-12):2015-7. PubMed ID: 526934 [TBL] [Abstract][Full Text] [Related]
51. Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lung. Killen JY; Mitchell EP; Hoth DF; Willis LL; Gullo JJ; Smith FP; Schein PS; Woolley PV Cancer; 1982 Oct; 50(7):1258-61. PubMed ID: 7104970 [TBL] [Abstract][Full Text] [Related]
52. Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in advanced breast cancer. A Phase II trial of the Southwest Oncology Group. Knight WA; O'Bryan RM; Samal B; Costanzi JJ Invest New Drugs; 1984; 2(1):71-3. PubMed ID: 6469501 [TBL] [Abstract][Full Text] [Related]
53. An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancer. Child JA; Bono AV; Fossa SD; Ten Bokkel Huinink WW; De Pauw M; Stoter G Eur J Cancer Clin Oncol; 1982 Jan; 18(1):85-7. PubMed ID: 7200896 [TBL] [Abstract][Full Text] [Related]
54. Phase II study of methyl-glyoxal bis-guanylhydrazone (NSC 3296) in advanced ovarian cancer. Vogl SE; Pagano M; Horton J Am J Clin Oncol; 1984 Dec; 7(6):733-6. PubMed ID: 6528867 [TBL] [Abstract][Full Text] [Related]
55. The effects of Methyl-GAG on a transplantable murine renal cell adenocarcinoma. Williams PD; Murphy GP Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):153-61. PubMed ID: 6844733 [TBL] [Abstract][Full Text] [Related]
56. An abbreviated phase II trial of thalicarpine. Leimert JT; Corder MP; Elliott TE; Lovett JM Cancer Treat Rep; 1980; 64(12):1389-90. PubMed ID: 6451289 [TBL] [Abstract][Full Text] [Related]
57. Phase II trials of methylglyoxal-bis (guanylhydrazone). Kelsen DP; Yagoda A; Warrell R; Chapman R; Whittes R; Gralla RJ; Casper E; Young CW Am J Clin Oncol; 1982 Apr; 5(2):221-5. PubMed ID: 7046414 [TBL] [Abstract][Full Text] [Related]
58. Phase I trial of homoharringtonine. Neidhart JA; Young DC; Derocher D; Metz EN Cancer Treat Rep; 1983 Sep; 67(9):801-4. PubMed ID: 6883357 [TBL] [Abstract][Full Text] [Related]
59. Phase II evaluation of MGBG in non-small cell carcinoma of the lung. A Southwest Oncology Group study. Vance RB; Knight WA; Chen TT; Costanzi JJ; LoBuglio AF Invest New Drugs; 1983; 1(1):89-93. PubMed ID: 6678859 [TBL] [Abstract][Full Text] [Related]
60. A phase I clinical and pharmacokinetic study of Brequinar sodium, DUP 785 (NSC 368390), using a weekly and a biweekly schedule. Bork E; Vest S; Hansen HH Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1403-11. PubMed ID: 2591433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]